| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $26.5M | — | — |
| R&D Expense | $29.5M | — | +53.3% |
| SG&A Expense | $10.3M | — | +50.0% |
| Operating Income | -$13.3M | — | +48.7% |
| Pre-tax Income | -$8.3M | — | +61.4% |
| Income Tax | $337K | — | — |
| Net Income | -$8.6M | — | +59.8% |
| EPS (Basic) | -$0.19 | — | +61.2% |
| EPS (Diluted) | -$0.19 | — | +61.2% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $71.6M | -40.7% | -65.9% |
| Short-term Investments | $275.8M | +2.0% | +119.0% |
| Accounts Receivable | $10.8M | +4.7% | +4236.8% |
| Current Assets | $368.1M | -10.4% | +7.5% |
| Total Assets | $569.7M | -4.4% | +31.3% |
| Current Liabilities | $78.2M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$25.6M | — | -9.8% |
| Capital Expenditures | $832K | — | +117.8% |
| Investing Cash Flow | -$23.8M | — | -388.7% |
| Financing Cash Flow | $333K | — | +404.5% |
| Free Cash Flow | -$26.5M | — | -11.5% |
| +634.8% |
| Total Liabilities | $191.2M | -10.7% | +466.5% |
| Stockholders' Equity | $378.5M | -0.9% | -5.4% |